M&A

Glaxo May Buy Theravance to Gain New Drugs, Piper Analysts Say
Bloomberg
Mon, 03/4/13 - 11:02 am
GSK
Theravance
M&A
Anoro
Breo Ellipta
Mylan to buy injectable drugs unit of India's Strides for $1.6 bln
Reuters
Thu, 02/28/13 - 10:50 am
Mylan
M&A
India
Strides Arcolab
injectables
Agila
Is Takeda Interested In Aastrom Bio?
Seeking Alpha
Wed, 02/27/13 - 12:28 pm
Takeda
Aastrom Biosciences
M&A
Royalty Pharma plans to tap Elan investors on offer -source
Reuters
Wed, 02/27/13 - 11:34 am
Elan
investors
M&A
Royalty Pharma
Royalty Pharma proposes $6.6 bln bid for Elan
Reuters
Mon, 02/25/13 - 10:30 am
M&A
Royalty Pharma
Elan
Elan Armed With Biogen Billions Hunts for Deals: Real M&A
Bloomberg
Mon, 02/25/13 - 10:12 am
Elan
Biogen Idec
M&A
Cubist Announces Exclusive Option to Acquire Adynxx
Yahoo
Mon, 02/25/13 - 10:10 am
Cubist Pharmaceuticals
Adynxx
AYX1
M&A
Endo Health new CEO suggests near-term sale unlikely, says Wells Fargo
The Fly on the Wall
Mon, 02/25/13 - 09:53 am
Endo Health Solutions
M&A
Pharma CEOs
Rajiv De Silva
China Biotech Week In Review: Regeneron Pharma, Bayer Start New Trial For DME Treatment
Seeking Alpha
Sun, 02/24/13 - 02:34 pm
Golong Medicine
Reckitt Benckiser
M&A
Sihuan Pharma
Regeneron
Luye Pharma Group
Bayer
Double-Crane Pharma
BGI-Shenzhen Extends Tender Offer For Complete Genomics, inc.
Yahoo/PR Newswire
Sun, 02/24/13 - 02:18 pm
BGI-Shenzhen
Complete Genomics
M&A
Bausch & Lomb Owner Said to Seek Banks for IPO as Sale Falters
Bloomberg
Fri, 02/22/13 - 10:49 am
Bausch & Lomb
IPO
M&A
InterMune Sale Looms as Lung Drug Nears FDA Nod: Real M&A
Bloomberg
Wed, 02/20/13 - 12:13 pm
FDA
InterMune
M&A
Esbriet
Biomarin: This Mid-Cap Pharmaceutical is a Prime Takeover Target
Motley Fool
Mon, 02/18/13 - 11:57 am
M&A
Biomarin
Sanofi
Genzyme
China Biotech In Review: Amgen To Build China Presence With Partnerships / M&A
Seeking Alpha
Sun, 02/17/13 - 12:07 pm
M&A
Shenghuo Pharmaceutical Holdings
Shanshi Medical Device
Amgen
OxOnc Development
Celgene
Mylan in exclusive talks to buy Strides Arcolab’s injectables unit
Economic Times, India
Fri, 02/15/13 - 11:02 am
Strides Arcolab
Mylan
injectables
M&A
Cardinal Health Agrees to Buy AssuraMed for $2.07 Billion
Bloomberg
Thu, 02/14/13 - 10:38 am
AssuraMed
Cardinal Health
M&A
Allergan and MAP: Pharma Buyout With a 60% Premium
Motley Fool
Wed, 02/13/13 - 10:24 am
Allergan
MAP Pharmaceuticals
M&A
Shire to Forest on Deal List for AstraZeneca: Real M&A
Bloomberg
Tue, 02/12/13 - 12:13 pm
Shire
Forest Labs
AstraZeneca
M&A
GSK, others weigh $3-4 billion deal for Brazilian drugmaker: sources
Reuters
Tue, 02/12/13 - 12:04 pm
GSK
M&A
Brazil
Ache Laboratorios Farmaceuticos
Reckitt in $482 mln deal to sell Bristol drugs in LatAm
Reuters
Tue, 02/12/13 - 10:54 am
Reckitt Benckiser
Latin America
M&A
Bristol-Myers Squibb
OTC

Pages